Literature DB >> 26986949

Expression of α-fetoprotein in gastric cancer AGS cells contributes to invasion and metastasis by influencing anoikis sensitivity.

Sumei Lu1, Yongmei Ma1, Tao Sun1, Rui Ren1, Xiaoning Zhang1, Wanshan Ma1.   

Abstract

α-fetoprotein (AFP) is a valuable tumor marker for many types of cancers, including primary gastric cancer (GC). However, the effects of AFP expression on the metastasis and anoikis sensitivity of GC remain unclear. The present study aimed to explore the role and possible mechanism of AFP in the invasion and metastasis of GC AGS cells, particularly in the anoikis sensitivity of AGS cells. In the present study, the expression of AFP in cultured AGS cells was assayed firstly by RT-PCR, western blotting and sequencing. Then, a specific AFP siRNA was applied to interfere with AFP expression and poly(2-hydroxyethyl methacrylate) (poly-HEMA) was used to block cell anchorage. The invasion and metastatic ability, and anoikis sensitivity detections were conducted based on Transwell chamber assay, anoikis assay kit and western blotting. Our results confirmed the expression of AFP in AGS cells. Then, we found that interference of AFP with siRNA attenuated the invasion and metastasis of AGS cells and induced a significant upregulation of E-cadherin and downregulation of N-cadherin expression (P<0.05). Cell apoptosis and anoikis were induced when cell anchorage was blocked by poly-HEMA treatment, which was exacerbated significantly when cells were exposed to AFP siRNA. Moreover, interference of AFP when cell anchorage was blocked enhanced the expression of the pro-apoptotic proteins Bax, caspase-3 and -9, and decreased the expression of the anti-apoptotic protein B-cell lymphoma-2 (Bcl-2). In conclusion, the present study demonstrated that interference of AFP reduced AGS cell invasion and metastasis by enhancing anoikis sensitivity. The present study provides new insight for the treatment of GC and suggests AFP as a potential therapeutic target by regulating anoikis sensitivity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26986949     DOI: 10.3892/or.2016.4678

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

1.  ER stress dependent microparticles derived from smooth muscle cells promote endothelial dysfunction during thoracic aortic aneurysm and dissection.

Authors:  Li-Xin Jia; Wen-Mei Zhang; Tao-Tao Li; Yan Liu; Chun-Mei Piao; You-Cai Ma; Yu Lu; Yuan Wang; Ting-Ting Liu; Yong-Fen Qi; Jie Du
Journal:  Clin Sci (Lond)       Date:  2017-06-07       Impact factor: 6.124

2.  HCRP-1 regulates EGFR-AKT-BIM-mediated anoikis resistance and serves as a prognostic marker in human colon cancer.

Authors:  Feifei Chen; Lei Zhang; Jianqiang Wu; Fuchun Huo; Xin Ren; Junnian Zheng; Dongsheng Pei
Journal:  Cell Death Dis       Date:  2018-12-05       Impact factor: 8.469

3.  Activated Wnt signaling promotes growth and progression of AFP-producing gastric cancer in preclinical models.

Authors:  Dongshao Chen; Xiaoting Lin; Cheng Zhang; Guo An; Zhongwu Li; Bin Dong; Lin Shen; Jing Gao; Xiaotian Zhang
Journal:  Cancer Manag Res       Date:  2019-02-11       Impact factor: 3.989

4.  Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features.

Authors:  Yakun Wang; Li Sun; Zhongwu Li; Jing Gao; Sai Ge; Cheng Zhang; Jiajia Yuan; Xicheng Wang; Jian Li; Zhihao Lu; Jifang Gong; Ming Lu; Jun Zhou; Zhi Peng; Lin Shen; Xiaotian Zhang
Journal:  Gastric Cancer       Date:  2019-04-15       Impact factor: 7.370

5.  miR-122-5p as a novel biomarker for alpha-fetoprotein-producing gastric cancer.

Authors:  Suguru Maruyama; Shinji Furuya; Kensuke Shiraishi; Hiroki Shimizu; Hidenori Akaike; Naohiro Hosomura; Yoshihiko Kawaguchi; Hidetake Amemiya; Hiromichi Kawaida; Makoto Sudo; Shingo Inoue; Hiroshi Kono; Daisuke Ichikawa
Journal:  World J Gastrointest Oncol       Date:  2018-10-15

6.  A scoring model combining serum alpha-fetoprotein and tumor size and number predicts prognosis in hepatitis B virus-related hepatocellular carcinoma patients after curative hepatectomy.

Authors:  Bai Wei; Jing-San Chen; Sheng-Li Yang; George G Chen; Hao He
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.